Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124783082 | 12478308 | 2 | F | 20160608 | 20160913 | 20160617 | 20160921 | EXP | US-ASTRAZENECA-2016SE64714 | ASTRAZENECA | 28133.00 | DY | M | Y | 83.90000 | KG | 20160921 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124783082 | 12478308 | 1 | PS | BYDUREON | EXENATIDE | 1 | Subcutaneous | 314 | MG | N | U | 22200 | 2 | MG | /wk | ||||
124783082 | 12478308 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | N | U | 0 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | ||||||||
124783082 | 12478308 | 3 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | DAILY | 0 | TABLET | |||||||||
124783082 | 12478308 | 4 | SS | OTC OMEPRAZOLE VARIOUS | OMEPRAZOLE | 1 | Oral | 0 | |||||||||||
124783082 | 12478308 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | |||||||||||
124783082 | 12478308 | 6 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
124783082 | 12478308 | 7 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 | ||||||||||||
124783082 | 12478308 | 8 | C | INSULIN | INSULIN NOS | 1 | 0 | ||||||||||||
124783082 | 12478308 | 9 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | 0 | ||||||||||||
124783082 | 12478308 | 10 | C | LOVASTATIN. | LOVASTATIN | 1 | 0 | ||||||||||||
124783082 | 12478308 | 11 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124783082 | 12478308 | 1 | Type 2 diabetes mellitus |
124783082 | 12478308 | 2 | Type 2 diabetes mellitus |
124783082 | 12478308 | 3 | Type 2 diabetes mellitus |
124783082 | 12478308 | 4 | Gastrooesophageal reflux disease |
124783082 | 12478308 | 5 | Type 2 diabetes mellitus |
124783082 | 12478308 | 8 | Type 2 diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124783082 | 12478308 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124783082 | 12478308 | Epigastric discomfort | |
124783082 | 12478308 | Gastrooesophageal reflux disease | |
124783082 | 12478308 | Papillary thyroid cancer |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124783082 | 12478308 | 1 | 201306 | 201607 | 0 | |
124783082 | 12478308 | 2 | 2008 | 201306 | 0 | |
124783082 | 12478308 | 3 | 1996 | 0 | ||
124783082 | 12478308 | 4 | 2015 | 0 | ||
124783082 | 12478308 | 5 | 1996 | 0 |